AI Hallucination ResearchFindings by audienceSectorsInternational / MultilateralPharmaceuticalsLegalDetail › Finding
Pharmaceuticals × Legal — International / Multilateral · Last updated 11 Jun 2026 · Hallucination Register
Share / Print X LinkedIn Email

Finding#2 : DSI benefit-sharing article misidentified

RLB Citation ID: RLB-F-INT-UNTC-BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023-Q004
AI's failure:Misattributed Risk for Pharmaceuticals × Legal:Legal exposure
What the RLB Specialist Panel found
Question (paraphrased to protect IP)

Does the BBNJ Agreement apply its marine genetic resources benefit-sharing obligations to specimens and genetic data collected from international waters before the agreement entered into force?

RLB's analysis

Sonnet 4.6 inverted the Article 10(1) default and added a fabricated first-commercialisation trigger that the treaty does not contain. The matched Opus 4.7 response on a parallel question produced the same inversion, indicating the failure is a shared corpus-level artefact rather than a single-model reasoning slip. The first-commercialisation construct appears to be inference drift from general bioprospecting commentary onto BBNJ provisions.

AI Head's analysis — what weakness in the AI model caused this

This finding implicates article-level precision in the training data. Sonnet 4.6 with web search correctly identified that digital sequence information derived from high-seas marine genetic resources is in scope of the BBNJ Agreement's benefit-sharing framework, but placed the obligation at Article 15(5). The duty actually sits at Article 14(1). The error is consistent with a model that has learned the topical summary (DSI is covered) without the article-level mapping practitioners need. Structured article-map extraction for this instrument would address this finding and the matched non-undermining-duty misattribution in the Opus 4.7 response.

Impact for Legal Teams in Pharmaceuticals Sector in international jurisdictions working with the BBNJ High Seas Biodiversity Agreement

A legal team at a pharmaceuticals firm advising on the BBNJ Agreement's digital sequence information benefit-sharing framework would, on this AI response, cite Article 15(5) as the source of the obligation. The DSI benefit-sharing duty actually sits at Article 14(1). The substantive conclusion that DSI is in scope is right; the article number is not. A legal opinion or transactional document carrying the wrong citation is defective on first review and undermines the credibility of the wider advice on the same instrument.

References — raw findings (per AI model)
This finding also affects
← Previous finding Finding#1 : MGR retroactivity default inverted
Cite this finding

Each finding has a stable Citation ID (RLB-F-… for aggregated case-study findings, RLB-H-… for raw per-model hallucinations) — like a DOI, the ID always resolves to the canonical finding even if URLs change.

RLB Citation ID: RLB-F-INT-UNTC-BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023-Q004
Plain text Download
RegLeg Specialist Panel (2026). "Finding#2 : DSI benefit-sharing article misidentified — Pharmaceuticals × Legal — International / Multilateral." Citation ID: RLB-F-INT-UNTC-BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023-Q004. RegLegBrief AI Hallucination Research, published 2026-06-11. https://reglegbrief.com/regulators/j1/int/UNTC/BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023/sectors/pharmaceuticals/legal/finding/INT-UNTC-INT-001-BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023-v1-004/
APA 7th edition Download
RegLeg Specialist Panel. (2026). Finding#2 : DSI benefit-sharing article misidentified [Hallucination finding RLB-F-INT-UNTC-BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023-Q004]. RegLegBrief AI Hallucination Research. https://reglegbrief.com/regulators/j1/int/UNTC/BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023/sectors/pharmaceuticals/legal/finding/INT-UNTC-INT-001-BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023-v1-004/
Bluebook / OSCOLA (US + UK legal) Download
RegLeg Specialist Panel, Finding#2 : DSI benefit-sharing article misidentified [RLB-F-INT-UNTC-BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023-Q004], RegLegBrief AI Hallucination Research (June 11, 2026), https://reglegbrief.com/regulators/j1/int/UNTC/BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023/sectors/pharmaceuticals/legal/finding/INT-UNTC-INT-001-BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023-v1-004/.
BibTeX Download
@misc{reglegbrief_RLB_F_INT_UNTC_BBNJ_HIGH_SEAS_BIODIVERSITY_AGREEMENT_2023_Q004,
  author    = {RegLeg Specialist Panel},
  title     = {Finding#2 : DSI benefit-sharing article misidentified},
  year      = {2026},
  publisher = {RegLegBrief AI Hallucination Research},
  note      = {Hallucination finding Citation ID: RLB-F-INT-UNTC-BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023-Q004},
  url       = {https://reglegbrief.com/regulators/j1/int/UNTC/BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023/sectors/pharmaceuticals/legal/finding/INT-UNTC-INT-001-BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023-v1-004/}
}
← Back to case study summary Case study detail →

Every finding on this page compares an AI subject's account of the rule against the regulator's verbatim text from the regulator's own portal. Both are linked. Each delta, its root causes, and impact analysis are documented and published with immutable Citation IDs.